Research Plan; Progress Reports Sample Clauses
The 'Research Plan; Progress Reports' clause establishes the requirement for the parties involved in a research agreement to create and follow a detailed research plan and to provide regular updates on the progress of the work. Typically, this clause outlines the expectations for the initial submission of a research plan, the format and frequency of progress reports, and the specific information that must be included in these updates, such as milestones achieved or challenges encountered. Its core practical function is to ensure transparency and accountability throughout the research project, enabling all parties to monitor progress, address issues promptly, and maintain alignment with the project's objectives.
Research Plan; Progress Reports. 4.1.1. Regen BioPharma, either directly or through a sublicensee, will develop a research plan summarizing the work it will perform and associated indicative timelines to Develop, obtain Regulatory Approval for and sell Licensed Products (the “Research Plan”). Regen BioPharma will provide a copy of the Research Plan to Benitec Australia within ninety (90) days of the Effective Date.
4.1.2. By September 1 of each calendar year, Regen BioPharma, either directly or through a sublicensee, will submit a written report to Benitec Australia covering the preceding twelve (12) month period. Each report will describe: Regen BioPharma’s progress, either directly or through a sublicensee, in accordance with the Research Plan and towards commercialization of Licensed Product, including work completed, key scientific discoveries, summary of work-in-progress, current schedules or anticipated events or milestones, market plans for introduction of Licensed Product, and significant corporate transaction(s) involving Licensed Product.
Research Plan; Progress Reports. (a) Chiva shall develop a research plan detailing the work it will perform and associated timelines to Develop Licensed Products and to obtain Regulatory Approval and sell Licensed Products (the “Research Plan”). Chiva will provide a copy of the Research Plan to Ligand within [* * *] and any updates as these become available from time to time. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
(b) By [* * *] and [* * *] of each year, Chiva shall submit a written report to Ligand covering the preceding [* * *] period. Each report will describe: Chiva’s progress in accordance with the Research Plan and towards commercialization of Licensed Products, including work completed, key scientific discoveries, summary of work-in-progress, current schedules or anticipated events or milestones, market plans for introduction of Licensed Product, and significant corporate transaction(s) involving Licensed Products. Chiva shall also provide to Ligand copies of any reports received from its sublicensees, within [* * *] of receipt.
Research Plan; Progress Reports. (a) Chiva shall develop a research plan detailing the work it will perform and associated timelines to Develop Products and to obtain Regulatory Approval and sell Products (the “Research Plan”). Chiva will provide a copy of the Research Plan to Ligand within [***] of the Effective Date and any updates as these become available from time to time.
(b) By [***] and [***] of each year, Chiva shall submit a written report to Ligand covering the preceding [***] period. Each report will describe: Chiva’s progress in accordance with the Research Plan and towards commercialization of Products, including work completed, key scientific discoveries, summary of work-in-progress, current schedules or anticipated events or milestones, market plans for introduction of Product, and significant corporate transaction(s) involving Products. Chiva shall also provide to Ligand copies of any reports received from its sublicensees, within [***] of receipt. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
Research Plan; Progress Reports. Chiva shall develop a research plan detailing the work it will perform and associated timelines to Develop Licensed Products and to obtain Regulatory Approval and sell Licensed Products (the “Research Plan”). Chiva will provide a copy of the Research Plan to Ligand within [***] of the Effective Date and any updates as these become available from time to time.
Research Plan; Progress Reports. Licensee shall develop a research plan detailing the work it will perform and associated timelines to Develop Products and to obtain Regulatory Approval and sell Products throughout the Territory (the “Research Plan”). Licensee will provide a copy of the Research Plan to Ligand within [***] of the Effective Date and any updates on an annual basis.